Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale

Objective We compared the measurement properties of a traditional physician global assessment of disease activity (PhGA) 10‐cm visual analog scale (PhGA0–10) with that of the three‐point numeric scale (PhGA0–3) in childhood‐onset systemic lupus erythematosus (cSLE) as part of the childhood Lupus Low...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekemini A. Ogbu, Anna Carmela P. Sagcal‐Gironella, B. Anne Eberhard, Jennifer M. Huggins, Marisa S. Klein‐Gitelman, Karen Onel, Chen Chen, Bin Huang, Hermine I. Brunner
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11737
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542377011576832
author Ekemini A. Ogbu
Anna Carmela P. Sagcal‐Gironella
B. Anne Eberhard
Jennifer M. Huggins
Marisa S. Klein‐Gitelman
Karen Onel
Chen Chen
Bin Huang
Hermine I. Brunner
author_facet Ekemini A. Ogbu
Anna Carmela P. Sagcal‐Gironella
B. Anne Eberhard
Jennifer M. Huggins
Marisa S. Klein‐Gitelman
Karen Onel
Chen Chen
Bin Huang
Hermine I. Brunner
author_sort Ekemini A. Ogbu
collection DOAJ
description Objective We compared the measurement properties of a traditional physician global assessment of disease activity (PhGA) 10‐cm visual analog scale (PhGA0–10) with that of the three‐point numeric scale (PhGA0–3) in childhood‐onset systemic lupus erythematosus (cSLE) as part of the childhood Lupus Low Disease Activity State (cLLDAS). Methods We used a secondary data analysis from a convenience sample of 100 patients with cSLE followed every three months for up to seven visits. Ratings of PhGA0–10, PhGA0–3, parent assessment of patient well‐being (ParGA) (range: 0= very poorly, 10 = very well), disease activity as measured by the SLE disease activity index 2000 (SLEDAI‐2k), Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) SLEDAI, and the British Isles International Lupus Activity Group index (BILAG; A = 9, B = 3, C = 1, D/E = 0) were compared. After linear transformation of PhGA0–10 to a 0 to 3 range (tPhGA0–10), the frequency of PhGA0–3 ≤1 was assessed to estimate the impact of scale type on the scoring of the cLLDAS. Results In 600 visits, the median (range) scores of PhGA0–10, PhGA0–3, SLEDAI‐2k, SELENA‐SLEDAI, and BILAG were 2 (0–10), 1(0–3), 4 (0–28), 4 (0–32), and 2 (0–28), respectively. PhGA0–10 and PhGA0–3 ratings were strong to moderately correlated with (r = 0.73; P < 0.0001) and with more variability for PhGA0–3 ≥2. SELENA‐SLEDAI and SLEDAI‐2k scores were moderately correlated with PhGA0–10 (r = 0.56/0.54; P < 0.0001). ParGA values were weakly correlated with all other measures considered (all r = −0.19 to −0.34). There were 490 of 600 visits with PhGA0−3 ≤1 and 497 of 600 visits with tPhGA0−10 ≤1 (κ (SE) =0.59 (0.04), McNemar P = 0.4). Conclusion PhGA0–3 and PhGA0–10 have comparable measurement properties and yield almost identical cLLDAS rates when used in cSLE.
format Article
id doaj-art-66e5d060a6da4c19aebf08d8ea5842c7
institution Kabale University
issn 2578-5745
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series ACR Open Rheumatology
spelling doaj-art-66e5d060a6da4c19aebf08d8ea5842c72025-02-04T06:21:23ZengWileyACR Open Rheumatology2578-57452025-01-0171n/an/a10.1002/acr2.11737Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog ScaleEkemini A. Ogbu0Anna Carmela P. Sagcal‐Gironella1B. Anne Eberhard2Jennifer M. Huggins3Marisa S. Klein‐Gitelman4Karen Onel5Chen Chen6Bin Huang7Hermine I. Brunner8Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, and Johns Hopkins University Baltimore MarylandHackensack Meridian School of Medicine Nutley New JerseyCohen Children's Medical Center Northwell, New Hyde Park New YorkCincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine Cincinnati OhioAnn & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine Chicago IllinoisHospital for Special Surgery, Weill Cornell Medicine New York New YorkCincinnati Children's Hospital Medical Center Cincinnati OhioCincinnati Children's Hospital Medical Center Cincinnati OhioCincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine Cincinnati OhioObjective We compared the measurement properties of a traditional physician global assessment of disease activity (PhGA) 10‐cm visual analog scale (PhGA0–10) with that of the three‐point numeric scale (PhGA0–3) in childhood‐onset systemic lupus erythematosus (cSLE) as part of the childhood Lupus Low Disease Activity State (cLLDAS). Methods We used a secondary data analysis from a convenience sample of 100 patients with cSLE followed every three months for up to seven visits. Ratings of PhGA0–10, PhGA0–3, parent assessment of patient well‐being (ParGA) (range: 0= very poorly, 10 = very well), disease activity as measured by the SLE disease activity index 2000 (SLEDAI‐2k), Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) SLEDAI, and the British Isles International Lupus Activity Group index (BILAG; A = 9, B = 3, C = 1, D/E = 0) were compared. After linear transformation of PhGA0–10 to a 0 to 3 range (tPhGA0–10), the frequency of PhGA0–3 ≤1 was assessed to estimate the impact of scale type on the scoring of the cLLDAS. Results In 600 visits, the median (range) scores of PhGA0–10, PhGA0–3, SLEDAI‐2k, SELENA‐SLEDAI, and BILAG were 2 (0–10), 1(0–3), 4 (0–28), 4 (0–32), and 2 (0–28), respectively. PhGA0–10 and PhGA0–3 ratings were strong to moderately correlated with (r = 0.73; P < 0.0001) and with more variability for PhGA0–3 ≥2. SELENA‐SLEDAI and SLEDAI‐2k scores were moderately correlated with PhGA0–10 (r = 0.56/0.54; P < 0.0001). ParGA values were weakly correlated with all other measures considered (all r = −0.19 to −0.34). There were 490 of 600 visits with PhGA0−3 ≤1 and 497 of 600 visits with tPhGA0−10 ≤1 (κ (SE) =0.59 (0.04), McNemar P = 0.4). Conclusion PhGA0–3 and PhGA0–10 have comparable measurement properties and yield almost identical cLLDAS rates when used in cSLE.https://doi.org/10.1002/acr2.11737
spellingShingle Ekemini A. Ogbu
Anna Carmela P. Sagcal‐Gironella
B. Anne Eberhard
Jennifer M. Huggins
Marisa S. Klein‐Gitelman
Karen Onel
Chen Chen
Bin Huang
Hermine I. Brunner
Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
ACR Open Rheumatology
title Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
title_full Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
title_fullStr Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
title_full_unstemmed Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
title_short Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
title_sort implementation of the lupus low disease activity state in pediatric rheumatology care the role of the visual analog scale
url https://doi.org/10.1002/acr2.11737
work_keys_str_mv AT ekeminiaogbu implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT annacarmelapsagcalgironella implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT banneeberhard implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT jennifermhuggins implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT marisaskleingitelman implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT karenonel implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT chenchen implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT binhuang implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale
AT hermineibrunner implementationofthelupuslowdiseaseactivitystateinpediatricrheumatologycaretheroleofthevisualanalogscale